Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling
Innate intratumoral immunity might be important in enhancing oncolytic tumor immunotherapy. Here, the authors show that recombinant poliovirus signalling through TBK-IRF3 enhances tumor-infiltrating T cell activity and multi-cytokine function.
Main Authors: | Michael C. Brown, Mubeen M. Mosaheb, Malte Mohme, Zachary P. McKay, Eda K. Holl, Jonathan P. Kastan, Yuanfan Yang, Georgia M. Beasley, E. Shelley Hwang, David M. Ashley, Darell D. Bigner, Smita K. Nair, Matthias Gromeier |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-22088-1 |
Similar Items
-
Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity
by: Mubeen M. Mosaheb, et al.
Published: (2020-01-01) -
TANK-Binding Kinase 1 (TBK1) Isoforms Negatively Regulate Type I Interferon Induction by Inhibiting TBK1-IRF3 Interaction and IRF3 Phosphorylation
by: Yi Wei Hu, et al.
Published: (2018-01-01) -
Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7.
by: Leonie Unterholzner, et al.
Published: (2011-09-01) -
Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors.
by: Xin Yu, et al.
Published: (2019-01-01) -
Molecular characterization, expression of chicken TBK1 gene and its effect on IRF3 signaling pathway.
by: Yan Wang, et al.
Published: (2017-01-01)